Perspective Therapeutics (CATX) EBT Margin Growth (1y) (2011 - 2023)
Perspective Therapeutics (CATX) EBT Margin Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -287.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 772.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -464.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 584.00 |
| 10 | Perspective Therapeutics | 304.08 Mn | 304.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -23,703.00 |
| Jun 30, 2023 | -65,745.00 |
| Mar 31, 2023 | -54,776.00 |
| Sep 30, 2022 | -14,944.00 |
| Jun 30, 2022 | -13,262.00 |
| Mar 31, 2022 | -1,763.00 |
| Dec 31, 2021 | -2,016.00 |
| Sep 30, 2021 | -5,757.00 |
| Jun 30, 2021 | 10,180.00 |
| Mar 31, 2021 | -973.00 |
| Dec 31, 2020 | 387.00 |
| Sep 30, 2020 | 534.00 |
| Jun 30, 2020 | 478.00 |
| Mar 31, 2020 | 3,976.00 |
| Dec 31, 2019 | 3,360.00 |
| Sep 30, 2019 | 6,129.00 |
| Jun 30, 2019 | 9,019.00 |
| Mar 31, 2019 | 2,600.00 |
| Dec 31, 2018 | 2,098.00 |
| Sep 30, 2018 | 3,112.00 |